首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1536006

大麻二酚 (CBD) 市場 - 按來源（大麻、大麻）產品（油、口服、外用、分離物、栓劑）、應用（焦慮、失眠、慢性疼痛、皮膚護理、偏頭痛）、給藥途徑、配銷通路、全球預測(2024 - 2032)

Cannabidiol (CBD) Market - By Source (Hemp, Marijuana) Product (Oil, Oral, Topicals, Isolates, Suppository), Application (Anxiety, Insomnia, Chronic Pain, Skin Care, Migraine), Route of Administration, Distribution Channel, Global Forecast (2024 - 2032)

出版日期: 2024年06月20日 | 出版商:

Global Market Insights Inc. | 英文 340 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在對其潛在效益的研究和開發不斷增加的推動下，全球大麻二酚 (CBD) 市場在 2024 年至 2032 年間的複合年成長率將達到 17.9%。隨著科學研究不斷探索 CBD 的治療特性，包括其緩解疼痛、焦慮和睡眠障礙的潛力，消費者的興趣正在擴大。

研究進展揭示了 CBD 在各種健康和保健產品中的新應用，從補充劑到護膚品。越來越多的證據支持 CBD 的功效和安全性，進一步增強了其市場吸引力。例如，2024 年 2 月，科羅拉多大學博爾德分校的新研究表明，富含無毒化合物 CBD 的大麻產品可能比以 THC 為主的產品更有效地緩解焦慮，並且沒有相關的副作用。

此外，監管變化和對大麻衍生產品的接受度提高也導致了需求的成長。尋求開發基於 CBD 的創新解決方案的公司對研發的持續投資對於塑造市場至關重要，因為它增強了理解，擴大了應用範圍，並建立了消費者對 CBD 好處的信任。這一趨勢強調了 CBD 市場的動態性質及其在健康產業中不斷變化的作用。

整個大麻二酚 (CBD) 產業根據來源、產品、應用、給藥途徑、配銷通路和地區進行分類。

消息人士透露，從2024 年到2032 年，大麻領域的大麻二酚(CBD) 市場收入將實現令人稱讚的複合年成長率。緩解疼痛、焦慮和焦慮的人的熱門選擇。消費者和研究人員越來越關注 CBD 的潛在健康益處及其在健康和醫療產品中的應用。這一趨勢強調了 CBD 在更廣泛的大麻市場中不斷變化的作用及其作為治療選擇的吸引力。

在產品方面，從2024年到2032年，口服CBD產品將出現顯著成長。日常生活中。這種給藥方法可確保劑量一致，並因其易於使用和有效管理焦慮、疼痛和睡眠障礙等病症而受到青睞。消費者對口服 CBD 產品的偏好的成長是由於其感知的益處、可靠性以及高品質、經過臨床測試的配方的不斷擴大的可用性。隨著人們對 CBD 的認知和接受度不斷提高，口服 CBD 產品不斷受到歡迎，刺激了市場需求。

歐洲大麻二酚(CBD) 市場從2024 年到2032 年將呈現顯著的複合年成長率。障礙。歐洲各國大麻衍生 CBD 產品合法化的不斷擴大正在推動市場擴張，零售和線上通路的可用性不斷增加。此外，人們對 CBD 治療效果的認知不斷增強，科學研究也促進了其受歡迎程度。隨著歐洲法規的發展以適應和標準化 CBD 產品，預計市場將繼續呈上升趨勢，反映出更廣泛的接受度和需求。

產業生態系統分析
產業影響力
- 成長動力
  - CBD 不斷成長的醫療應用
  - 由於政府批准，產品的採用和使用增加
  - 改變跨區域 CBD 產品核准的監管環境
  - 零售店 CBD 產品的銷售增加
- 產業陷阱與挑戰
  - 與 CBD 油相關的副作用
  - 市面上有假冒和合成產品
  - CBD產品成本高
  - 處方流程複雜
成長潛力分析
監管環境
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按來源分類，2021 - 2032 年

主要趨勢
大麻
麻

第 6 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
油
- 全譜CBD油
- 廣譜CBD油
專題
- 經皮貼劑
- 乳霜和走珠
口服
- 藥片
- 膠囊
- 酊劑
CBD吸入器
栓劑
分離物
電子煙油
其他產品

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
焦慮/壓力
睡眠/失眠
慢性疼痛
偏頭痛
皮膚護理
癲癇發作
關節疼痛和炎症
其他應用

第 8 章：市場估計與預測：按管理途徑，2021 年至 2032 年

主要趨勢
口服
專題
吸入
經皮貼劑
直腸
舌下含化

第 9 章：市場估計與預測：按配銷通路，2021 - 2032

主要趨勢
線上
離線
- 醫院藥房
- 零售店

第 10 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Aurora Cannabis
Charlotte's Web
Canopy Growth Corporation
CV Sciences, Inc.
Endoca
Elixinol
Folium Biosciencesilray
Gaia Herbs, LLC,
GW Pharmaceuticals
Isodiol International Inc
KOI CBD
Medical Marijuana, Inc.
Medterra
NuLeaf Naturals, LLC,
Tterrapharma
Tilray
Vapen CBD

簡介目錄

Product Code: 4541

Global Cannabidiol (CBD) Market will witness 17.9% CAGR between 2024 and 2032, driven by rising research and development into its potential benefits. As scientific studies continue to explore CBD's therapeutic properties, including its potential for alleviating pain, anxiety, and sleep disorders, consumer interest is expanding.

Research advancements are uncovering new applications for CBD in various health and wellness products, ranging from supplements to skincare. This growing body of evidence supports CBD's efficacy and safety, further fueling its market appeal. For instance, in February 2024, new research from CU Boulder indicated that cannabis products high in the non-intoxicating compound CBD may alleviate anxiety more effectively than THC-dominant products and without the associated side effects.

Additionally, regulatory changes and increased acceptance of hemp-derived products contribute to the rising demand. The continuous investment in R&D by companies seeking to develop innovative CBD-based solutions is pivotal in shaping the market, as it enhances understanding, broadens applications, and builds consumer trust in CBD's benefits. This trend underscores the dynamic nature of the CBD market and its evolving role in the wellness industry.

The overall Cannabidiol (CBD) Industry is classified based on the source, product, application, route of administration, distribution channel, and region.

Based on source, the cannabidiol (CBD) market revenue from the marijuana segment will register a commendable CAGR from 2024 to 2032. As interest in cannabis-derived products rises, CBD has become a popular choice for those seeking relief from pain, anxiety, and other health issues without the psychoactive effects of THC. Consumers and researchers alike are increasingly drawn to CBD's potential health benefits and its applications in wellness and medical products. This trend underscores the evolving role of CBD in the broader cannabis market and its appeal as a therapeutic option.

In terms of product, the oral segment will witness an appreciable growth from 2024 to 2032. Oral CBD products, such as capsules, tinctures, and gummies, offer a convenient and discrete method for users to incorporate CBD into their daily routines. This delivery method ensures consistent dosing and is favored for its ease of use and effectiveness in managing conditions like anxiety, pain, and sleep disorders. The growth in consumer preference for oral CBD products is driven by their perceived benefits, reliability, and the expanding availability of high-quality, clinically tested formulations. As awareness and acceptance of CBD increase, oral CBD products continue to gain popularity, boosting market demand.

Europe cannabidiol (CBD) market will exhibit a notable CAGR from 2024 to 2032. European consumers are increasingly turning to CBD for its potential health benefits, including relief from anxiety, pain, and sleep disorders. The expanding legalization of hemp-derived CBD products across various European countries is driving market expansion, with increased availability in retail and online channels. Additionally, growing awareness and scientific research into CBD's therapeutic effects contribute to its popularity. As European regulations evolve to accommodate and standardize CBD products, the market is expected to continue its upward trajectory, reflecting broader acceptance and demand.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing medical applications of CBD
  - 3.2.1.2 Increasing product adoption and utilization owing to government approvals
  - 3.2.1.3 Changing regulatory landscape for approval of CBD products across region
  - 3.2.1.4 Increasing sales of CBD products in retail stores
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Side effects associated with CBD oil
  - 3.2.2.2 Counterfeit and synthetic products available in the market
  - 3.2.2.3 High cost of CBD products
  - 3.2.2.4 Complex prescription process
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Marijuana
5.3 Hemp

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oil
- 6.2.1 Full-spectrum CBD oil
- 6.2.2 Broad-spectrum CBD oil
6.3 Topicals
- 6.3.1 Transdermal patches
- 6.3.2 Creams and roll-on
6.4 Oral
- 6.4.1 Tablet
- 6.4.2 Capsules
- 6.4.3 Tinctures
6.5 CBD inhalers
6.6 Suppository
6.7 Isolates
6.8 Vape oil
6.9 Other products

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Anxiety/ stress
7.3 Sleep/insomnia
7.4 Chronic pain
7.5 Migraines
7.6 Skin care
7.7 Seizures
7.8 Joint pain & inflammation
7.9 Other applications

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Oral
8.3 Topical
8.4 Inhalation
8.5 Transdermal patches
8.6 Rectal
8.7 Sublingual

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Online
9.3 Offline
- 9.3.1 Hospital pharmacy
- 9.3.2 Retail stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa